Update on xerostomia: Current treatment modalities and future trends

General Dentistry

Volumn 54, Issue 2, 2006, Pages 99-101

  Givens Jr , Edward ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALIVA SUBSTITUTE;

ACUPUNCTURE; DRUG EFFECT; FORECASTING; GENE TRANSFER; HUMAN; REVIEW; SALIVATION; TISSUE REGENERATION; TRANSCUTANEOUS NERVE STIMULATION; XEROSTOMIA;

ACUPUNCTURE THERAPY; FORECASTING; GENE TRANSFER TECHNIQUES; GUIDED TISSUE REGENERATION; HUMANS; SALIVA, ARTIFICIAL; SALIVATION; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; XEROSTOMIA;

EID: 33646374412     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Ship JA, Pillemer SR, Baum BJ. Xerostomia and the geriatric patient. J Am Geriatr Soc 2002;50:535-543.
2. Amerongen AV, Veerman EC. Saliva - The defender of the oral cavity. Oral Dis 2002;8:12-22.
3. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral & maxillofacial pathology, ed. 2. Philadelphia: W.B. Saunders Co.;2002:398-399.
4. Lamey PJ, Darwazeh AM, Frier BM. Oral disorders associated with diabetes mellitus. Diabet Med 1992;9:410-416.
5. Bardow A, Nyvad B, Nauntofte B. Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol 2001;46:413-423.
6. Rhodus NL, Bereuter J. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjogren's syndrome. J Otolaryngol 2000;29:28-34.
7. Warde P, Kroll B, O'Sullivan B, Aslanidis J, Tew-George E, Waldron J, Maxymiw W, Liu FF, Payne D, Cummings B. A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Support Care Cancer 2000;8:203-208.
8. Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 1999;35:132-137.
9. Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: Efficacy and safety. Oral Dis 2002;8:23-29.
10. Grisius MM. Salivary gland dysfunction: A review of systemic therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:156-162.
11. Wiseman LR, Faulds D. Oral pilocarpine: A review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995;49:143-155.
12. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, Muscoplat CC, Gallagher SC. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. New Engl J Med 1993;329:390-395.
13. Gorsky M, Epstein JB, Parry J, Epstein MS, Le ND, Silverman S Jr. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:190-195.
14. Hamada T, Nakane T, Kimura T, Arisawa K, Yoneda K, Yamamoto T, Osaki T. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: A clinical trial. Am J Med Sci 1999;318:146-151.
15. Schiodt M, Oxholm P, Jacobsen A. Treatment of xerostomia in patients with primary Sjogren's syndrome with sulfarlem. Scand J Rheumatol Suppl 1986;61:250-252.
16. Stewart CM, Jones AC, Bates RE, Sandow P, Pink F, Stillwell J. Comparison between saliva stimulants and a saliva substitute in patients with xerostomia and hyposalivation. Spec Care Dent 1998;18:142-148.
17. Khurshudian AV. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjogren's Syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:38-44.
18. Perminova IS, Goidenko VS, Rudenko IV. [Experience with using reflexotherapy in treating Sjogren's syndrome]. Stomatologiia (Mosk) 1981;60:37-38.
19. Blom M, Lundeberg T. Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis 2000;6:15-24.
20. Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T. Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides 1999;33:244-250.
21. Wong RK, Jones GW, Sagar SM, Babjak AF, Whelan T. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:472-480.
22. Vitolo JM, Baum BJ. The use of gene transfer for the protection and repair of salivary glands. Oral Dis 2002;8:183-191.
23. O'Connell AC, Baccaglini L, Fox PC, O'Connell BC, Kenshalo D, Oweisy H, Hoque AT, Sun D, Herscher LL, Braddon VR, Delporte C, Baum BJ. Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther 1999;6:505-513.
24. Joraku A, Sullivan CA, Yoo JJ, Atala A. Tissue engineering of functional salivary gland tissue. Laryngoscope 2005;115:244-248.
25. Aframian DJ, David R, Ben-Bassat H, Shai E, Deutsch D, Baum BJ, Palmon A. Characterization of murine autologous salivary gland graft cells: A model for use with an artificial salivary gland. Tissue Eng 2004;10:914-920.
26. Fox PC. Acquired salivary dysfunction. Drugs and radiation. Ann N Y Acad Sci 1998;842:132-137.